The $19 billion WhatsApp deal could become the Facebook founder's legacy . . . or his albatross.
VIDEO ON MSN MONEY
Passing on Transatlantic and buying into IBM signals a change in investment strategy.
Warren Buffett's Berkshire Hathaway (BRK.B) rarely loses a deal fight, which makes Monday's news that the legendary investor was outbid for reinsurer Transatlantic Holdings (TRH) seem like a strange sight.
However, the fact that Berkshire lost out in a hotly contested bid to a competitor a nearly a tenth of its size in Alleghany Corporation (Y) should not be so surprising, given the Omaha, Neb., holding company's move away from its traditional reinsurance and insurance base and its shift to a more diversified portfolio of industrial companies.
Capital Advisors Growth Fund manager Keith Goddard works to limit losses while maintaining potential for aggressive growth.
All too often, large growth funds have followed a volatile pattern. During bull markets, the growth funds soared as investors bid up prices of fast-moving technology and consumer stocks. Then the rally ended and growth stocks crashed hard as overvalued shares sank.
Because of the regular collapses, the large growth category has often trailed large value. From 1928 through 2010, large growth stocks returned 8.8% annually, compared to a figure of 11.1% for large value, according to Ibbotson Associates. In recent years, growth stocks have sunk twice -- after the Internet bubble burst in 2000 and when the financial crisis unfolded in 2008. Hurt by the downturns, large growth funds trailed the S&P 500 ($INX) during the past decade, while large value funds outdid the benchmark.
The stock has now dropped below its $20-per-share IPO price.
Updated: 4:35 p.m. ET
Shares of Groupon (GRPN), which soared 40% two weeks ago during the daily deal site's IPO, continued to crater on Wednesday.
The stock fell 15.5% to $16.96. The session low was $16.84. Volume continued to be elevated with more than 5 million shares changing hands by midday. Wednesday's decline follows a 15% drop on Tuesday.
The health care products maker is spending $325 million on a private company to bolster its presence in the gastrointestinal diseases therapy space.
By: Zacks Equity Research
Leading health care products maker Covidien (COV) has cut a deal to buy the outstanding shares of Barrx Medical for $325 million, hoping the move will boost its presence in the gastrointestinal diseases therapy space.
Barrx Medical makes ablation catheters and other devices for treating gastrointestinal diseases and Barrett’s esophagus syndrome, a pre-cancerous condition of the lining of the esophagus.
The farm machinery maker saw quarterly sales rise 20% from a year earlier to $8.6 billion.
Deere & Co. (DE) outperformed in its fourth quarter, riding a wave of strong demand for farm machinery and increased sales of construction equipment.
The equipment maker delivered earnings of $1.62 per share in the quarter ended Oct. 31, comfortably exceeding the Zacks Consensus Estimate of $1.44. Results were 51% ahead of the $1.07 earned in the year-ago quarter.
Early indicators show that Black Friday could be a hit for retailers. Will the rest of the holiday season follow suit?
Retailers are hoping that their enthusiasm signals a strong performance for Black Friday, the traditional start of the holiday season. The National Retail Federation recently said that more Americans say they plan to shop for Black Friday bargains than last year. Consumer confidence rose in November to its highest level in November to its highest level in five months.
The two drug companies end a rocky 10-year partnership. What's next for Amylin?
Amylin (AMLN) made news recently when it was announced that Eli Lilly (LLY) had broken a deal between the companies for two Type 2 diabetes treatments, Byetta and Bydureon.
Amylin has also settled a marketing lawsuit it filed against Lilly this year alleging anti-competitive activity after Lilly entered into a marketing deal with Boehringer Ingelheim to sell a competing diabetes drug.
The divorce ends a rocky 10-year partnership between the two companies.
We expect the automaker to rein in development costs after completing work on the Model S and a new plant.
But Tesla's costs also increased substantially year over year, primarily due to higher research and development expenses.
While the market's pullback to key support is a caution sign for now, it’s also likely to result in a rally next week -- one critical to the market’s intermediate-term future.
By Tom Aspray, MoneyShow.com
The heavy selling Monday and additional losses on Tuesday have taken the major averages to the next key areas of support. Additional selling in the S&P futures early Wednesday has taken them below the 50% Fibonacci support levels.
For those not familiar with Fibonacci analysis, if prices break below the 50% support, it implies that prices will then drop to the 61.8% support. A daily close below that level will give confirmation that the trend has changed from up to down. Of course, in declining markets, we watch to see if the 38.2% retracement resistance is overcome, and if it is, we then look at the 50% and 61.8% retracement resistance levels.
The aircraft maker's recent 200-plane order from American Airlines' parent now looks a lot shakier.
Although the congressional supercommittee's colossal failure this week points to the near certainty of massive defense cuts, few analysts are shedding tears for Boeing (BA) right now. One reason is the nearly $40 billion in orders the aircraft maker has booked this month alone.
JPMorgan has brought in the most investment banking revenue for at least seven consecutive quarters, but it may lose its crown as 2011 comes to a close.
JPMorgan's investment banking division has brought in more revenues than its counterparts at other banks in every quarter going back to at least the first quarter of last year, according to the Barclays Capital report, which cites Dealogic data.
With no way of knowing how the eurozone crisis will play out, investors should continue to exercise extreme caution by holding cash and high-yield stocks.
So many disparate voices. So many people talking to you. The IMF on a lifeline -- how big? A Spanish prime minister. An aide close to Merkel. Someone close to Sarkozy. Nameless people in the Greek government. Finance ministry people from Italy. ECB bureaucrats. Who the heck knows?
And that's what's so hard about this tape. Sure, we can look to the CurrencyShares Euro Trust (FXE). When it drops off, we know we are going to have a tough day, but all we can do is root around to find out why it is dropping off.
Believe it or not, technical and fundamental underpinnings signal gains ahead. These stock picks make sense now.
Don't panic. That's the No. 1 rule that investors should keep in mind during intensely volatile market swings. More specifically, investors should not be goaded into panic selling.
I am aware that that isn't easy to do. But the market will get better. In fact, several seasoned and savvy pros argue that the market's current technical and fundamental underpinnings signal that it's time to buy U.S. stocks ahead of what they expect will be a sharp snap-back in equity prices.
Demand for office products is closely tied to the health of the economy, which is showing no sign of revival.
Staples (SPLS) unveiled its third-quarter results on Nov. 15. The quarterly earnings of 47 cents a share came in line with the Zacks Consensus Estimate and jumped 14.6% from 41 cents earned a year earlier.
Total sales of $6.57 billion were up .5% from the prior-year quarter but below the Zacks Consensus Estimate of $6.7 billion. North American delivery sales grew 1.8%, North American retail sales inched up .5% but international sales contracted 1.9%.
This pick is the best way to play an anticipated price increase.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
The push is on for undervalued, cash-rich technology companies to return more money to investors. And there's still room for dividend growth.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The S&P 500 (-0.1%) continues trading just below its flat line.
So far this week, participants have not received any market-moving data points, but tomorrow's retail sales report for February could potentially elicit a reaction from the market. The Briefing.com consensus expects the reading to indicate growth of 0.2% after last month's 0.4% decline.
Outside of retail sales, participants will also receive weekly initial claims (consensus 329K), export and import ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|